Navigation Links
Vivisimo Search Delivers Medical Knowledge to Global Health-Care Community
Date:12/17/2008

d implementing them requires vision for what search can do, and the drive to get it done," said Raul Valdes-Perez, CEO of Vivisimo. "Health Systems Online can dramatically improve the lives of people throughout the world and it exists because of a personal vision made possible by enterprise search. It's a vision Vivisimo is proud to help bring to life."

Vivisimo's Velocity Search Platform federates and crawls tens of thousands of source documents, and provides multi-language translation as specified by the user. Information is selected by clinicians and other experts from existing, reliable sources and is maintained and updated by HSO's partner organizations, including medical specialty societies, accredited continuing education organizations, governments, and top-ranked universities.

About Vivisimo, Inc.

Vivisimo provides enterprises with innovative search solutions that allow end-users to find and take advantage of all appropriate and available information, regardless of source, location or type. Vivisimo's innovative technology, including social search tools that enable collaboration throughout the enterprise, is delivered with a focus on end-user satisfaction and on application control through easy-to-use interfaces, flexible security management and a modern architecture that enables quick deployment. Vivisimo products are available for standalone search applications or as OEM versions embedded as critical search technology within partner applications and solutions. Vivisimo serves its global clients from headquarters in Pittsburgh, USA, and through partners around the world. Visit Vivisimo.com and our [Search Done Right] (TM) blog.

     Geof Becker
     Vivisimo
     (412) 422-2499 X166
     becker@Vivisimo.com

'/>"/>
SOURCE Vivisimo
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Vivisimo Helps OnMedica Deliver Personalized Search and Extend Social Search to Public-Facing Health Portal
2. Vivisimo Case Studies Detail Innovative Enterprise Search Applications by Medical Libraries, Womens Health Site
3. Strategic Domain Announces 30-Point Search Engine Optimization Check-up for Web Sites
4. UIC researchers hunting drugs for devastating parasitic disease
5. Researcher refining synthetic molecules to prevent HIV resistance
6. National CTE Research Center Outlines Projects
7. Indiana University researchers revisit male bisexuality
8. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
9. DNA Jewel to Finance Anti-Aging Services & Cancer Research
10. Breast cancer risk varies in young women with benign breast disease, Mayo Clinic researchers say
11. Mayo researchers find potential links between breast density and breast cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Free Health Clinic Event Is Not Just for the Sick 2
...tors for SCAN Health,Plan Arizona and SCAN Long Te...Lescault as president of SCAN,s Arizona operations... health plan for Medicare and,Medicaid-eligible in.../www.newscom.com/cgi-bin/prnh/20080701/LATU551 ), ...
...Chief Financial Officer, OAKLAND, Calif., July 1 ...ldHeart" or the "Corporation") announced today,tha...from the NASDAQ Stock,Market stating that the Corp...licly held shares ("MVPHS") of $1,000,000.,Therefo...
...llis Healthcare,REIT, Inc. today announced the acq...3 healthcare-related properties comprising 20 buil...ortfolio 3 consists of approximately 689,000 squar...of the 13,properties for an approximate gross leas...
...ion with,its second quarter 2008 earnings release ...30), Covance Inc. (NYSE: CVD ) is pleased to invi...nce call that will be broadcast,live over the Inte...y 31, 2008, 9:00 a.m. ET*, Where: http://www.co...
... affect development, researcher says , , T...abies receiving intensive care must undergo numero... to reduce their discomfort, new research suggests...armacological pain therapy. That means about four ...
...archers have demonstrated that the administration ...en sulfide, or H2S the molecule that gives rotten...es survival from extreme blood loss in rats. , Cel...n Robert K. Winn, Ph.D., and colleagues at UW Medi...
Other Medicine News:Health News:SCAN Health Plan Arizona and SCAN Long Term Care Appoints Thomas Lescault President of Arizona Operations 2Health News:WorldHeart Receives Non-Compliance Letter From NASDAQ Stock Market 2Health News:WorldHeart Receives Non-Compliance Letter From NASDAQ Stock Market 3Health News:Grubb & Ellis Healthcare REIT Acquires Medical Portfolio 3 in Indianapolis 2Health News:Grubb & Ellis Healthcare REIT Acquires Medical Portfolio 3 in Indianapolis 3Health News:Newborns in Intensive Care Often Exposed to Pain 2Health News:Newborns in Intensive Care Often Exposed to Pain 3Health News:'Hibernation-on-demand' drug significantly improves survival after extreme blood loss 2Health News:'Hibernation-on-demand' drug significantly improves survival after extreme blood loss 3
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB 728 T for HIV AIDS 14909 1Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB 728 T for HIV AIDS 14909 2FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for Americas Disabled Veterans 6392 1FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for Americas Disabled Veterans 6392 2Genital Herpes May Never Go Dormant 61659 1Genital Herpes May Never Go Dormant 61659 2Genital Herpes May Never Go Dormant 61659 3
...xpansion of Company,s Phase 3 Study for Wet AMD af...ata, FREMONT, Calif., April 17 NeoVista, Inc. an...ration (FDA) has granted the,company,s request to ...votal Phase 3 trial from 10 to 30 in the United St...ndary to AMD Treated with BEta RadiatioN,Epiretina...
...il 17 Innocoll, Inc., a privately-held,biopharmac...e planned phase,2 clinical trials sponsored by its...d, to investigate CollaRx(R) GENTAMICIN TOPICAL fo...c foot ulcers, has commenced,dosing. CollaRx GENTA...ble,Gentamicin-Collagen Sponge formulated and manu...
Other Medicine Technology:FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S. 2FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S. 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 4
...edical Professional Diagnostics is a leading provi...e IFA and DFA test menu that includes kits for aut...well as miscellaneous conjugates and components. O...ent of substrates and kit sizes to choose from. Ki...
...edical Professional Diagnostics is a leading provi...e IFA and DFA test menu that includes kits for aut...well as miscellaneous conjugates and components. O...ent of substrates and kit sizes to choose from. Ki...
...edical Professional Diagnostics is a leading provi...e IFA and DFA test menu that includes kits for aut...well as miscellaneous conjugates and components. O...ent of substrates and kit sizes to choose from. Ki...
... of infectious disease ELISA products make us a le...for faster integration into the busy laboratory, o...ased reliability and run-to-run consistency. Our I...ection assays for a wide range of serological assa...
Medicine Products: